- About
- Research
- Product
- Medical Use
- CelltimaX
- HOME
- ABOUT
- RESEARCH
- INSIGHTS & HAPPENINGS
- JOIN US
- CONTACT US
-
CelltiMax is Mesenchymal Stem Cells (MSCs) derived from human umbilical cords. Upon treatment, the cultured cells are injected intramuscularly / intravenously into the patient. The cells are characterized by low immunogenicity. Hence, it is very safe, tolerable and free of side effects. It has the capability to differentiate into specialized cells with specific functions for many parts of the body. They can reduce inflammation, repair, renew, regenerate, and replace damaged cells.
The fields of cellular research and regenerative medicine are rapidly expanding and have the potential to revolutionize how health is treated. Instead of focusing solely on treating symptoms, the aim is to restore or replace damaged tissues or organs caused by illness, trauma, or congenital problems.
Cell Tissue, a leading provider of Tissue Engineering and Stem Cells Technologies in Malaysia, aims to enhance natural healing in areas where it is most needed or replace permanently destroyed organs through the innovative RegenMed™ Research. This superior therapeutic option addresses disorders without the severe side effects commonly associated with traditional treatments.
We introduced RegenMed™️ Research as our medical innovation; an avant-garde force focused on three key areas:
Stem cells are the body’s raw materials — cells from which all other cells with specialized functions are created.
MSCs, adult stem cells, are one of the most extensively studied cell types for regenerative therapies. Adult stem cells have self-renewal, immunomodulatory, anti-inflammatory, signalling, and differentiation properties. Due to their regenerative effects, MSCs are very effective for many autoimmune and inflammatory medical conditions, making our standardised protocol suitable for many patients.
MSCs work by being able to differentiate into other types of cells such as:
• Bone cells
• Cartilage cells
• Muscle cells
• Fat cells
• Nerve cells
Ability to replicate indefinitely (go through numerous cycles of cell division while maintaining its undifferentiated state).
Stem cells are multi-potent and have the ability to grow and develop into several different cell types.
Ability to identify problems/inflamed area in our body and therefore it will transport to the area for repair.
It is a degenerative neurologic condition that results in the death of brain cells and brain shrinkage. Alzheimer’s Disease is the most common cause of dementia, which is characterised by a steady deterioration in mental, behavioural, and social abilities and affects a person’s ability to function independently.
A stroke, also known as a brain attack, occurs when blood flow to a certain area of the brain is blocked or when a blood vessel in the brain ruptures. This can lead to damage or death of brain cells. A stroke can result in permanent brain damage, disability, or even death.
Autism, or Autism Spectrum Disorder (ASD), refers to a broad range of conditions characterized by challenges with social skills, repetitive behaviours, speech and nonverbal communication. People with this condition may also have different ways of learning, moving, or paying attention.
Parkinson’s disease is a brain disorder that causes unintended or uncontrollable movements, such as shaking, stiffness, and difficulty with balance and coordination. Symptoms usually begin gradually and worsen over time. As the disease progresses, people may have difficulty walking and talking.
Chronic Kidney Disease (CKD) is characterized by a gradual loss of kidney function over time. CKD includes conditions that damage the kidneys and decrease their ability to keep individuals healthy by filtering wastes from their blood. If kidney disease worsens, wastes can build to high levels in your blood and make the patient feels sick.
CelltiMax provides regenerative results by seeking out areas of damage, paracrine signaling, regulating immune responses, and positively affecting human microbiology.
CelltiMax can provoke complex immunomodulatory mechanisms that can regulate and “calm” an overactivated immune system seen in many autoimmune conditions.
Studies have shown that, besides their ability to differentiate into distinct cell types, CelltiMax also exert therapeutic effects by cell “enhancement”, through the release of trophic and anti-inflammatory factors, which may re-establish physiological environment.
CelltiMax find areas of damage through paracrine signaling and can differentiate into a variety of different cell types. This function can improve scarring and potentially increase organ function throughout the body.
One week before treatment:
• Refrain from drinking alcohol, smoking, and taking unnecessary remedies.
• Avoid sunbathing, sauna, exposure to X-rays and excessive physical strains.
• Drink more plain water than usual (at least 1.5 litres).
• Do a blood test.
• Recommended after a course of treatment; 2 – 3 days rest.
• Your doctor should advices on the proper amount based on individual conditions.
• Avoid / refrain from smoking and physical exertion.
• Special diet and medicines to be taken within this period is up to the discretion of the physician.
• After administration, one can feel increased vitality and experience improvement in their condition.
• May initially experience slight fatigue and short-term emotional distress but will transition into a more relaxed phase within two weeks.
• Healing effect becomes evident within the third or fourth week and lasts a minimum of four to six months.
• Noticeable improvement in general health – physically and mentally, improvement in functions of targeted organs, nutrition supply, and overall health.
Founded in 2010, Cell Tissue Group is a pioneering Malaysian medical technology company and a spin-off from the National University of Malaysia (UKM). As Malaysia’s first Tissue Engineering firm, Cell Tissue Group operates within a certified cGMP laboratory, ensuring the highest standards of medical research and product development, particularly in Tissue Engineering and Regenerative Medicine.
Founded in 2010, Cell Tissue Group is a pioneering Malaysian medical technology company and a spin-off from the National University of Malaysia (UKM). As Malaysia’s first Tissue Engineering firm, Cell Tissue Group operates within a certified cGMP laboratory, ensuring the highest standards of medical research and product development, particularly in Tissue Engineering and Regenerative Medicine.
Proudly powered by CTG © 2010-2024 Cell Tissue Group, a Universiti Kebangsaan Malaysia Spin-Off Company. – All Rights Reserved.